Brain Health 101
Introduction
Importance of brain health
Brain health is the foundation of overall well-being, essential for not only cognitive functions like memory and attention but also physical ability. When the brain is functioning optimally, it’s better equipped to solve problems, tap into creativity, and maintain emotional resilience. Focusing on key factors like nutrition, stress management, and reducing exposure to environmental toxins can significantly boost cognitive function and protect against cognitive decline. Taking proactive steps to nurture the brain can lead to improved quality of life and sustained mental acuity well into old age.
Root cause perspective on brain health
A comprehensive approach to brain health must address the root causes of cognitive decline, which may include chronic inflammation, insulin resistance, oxidative stress, mitochondrial dysfunction, and nutrient deficiencies.
The gut-brain axis is also critical, as imbalances in gut microbiota can lead to increased intestinal permeability, or “leaky gut,” triggering systemic inflammation that worsens brain health1,2. The gut microbiomes of individuals with Parkinson’s disease show significant alterations, potentially linked to intestinal inflammation and gastrointestinal symptoms3. These changes involve species like Akkermansia, Faecalibacterium, and Prevotella, with similar patterns also seen in other neurological disorders, such as Alzheimer’s disease4.
Environmental toxins like heavy metals and mold can further contribute to neuroinflammation and cognitive decline5,6. Optimizing diet, enhancing gut health, minimizing toxin exposure, managing stress, getting sufficient sleep, and staying physically active are effective strategies to address the root causes of cognitive decline and support optimal brain function7.
Boosting brain health for a longer, healthier life: the key to extending healthspan and longevity
Optimal brain health is intrinsically linked to extended healthspan and increased longevity8, playing a critical role in reducing the risk of chronic diseases, such as cardiovascular disease and type 2 diabetes.
Poor brain health is associated with chronic systemic inflammation and insulin resistance9. For instance, poor blood sugar regulation can contribute to what is often referred to as “type 3 diabetes,” highlighting the strong connection between insulin resistance and the development of chronic neurodegenerative conditions like Alzheimer’s disease10.
Adopting a nutrient-dense diet, engaging in regular physical activity, managing stress, and prioritizing proper sleep can bolster mental clarity, focus, and energy levels. This will ultimately lead to better performance, improved mood, and a more vibrant, sustained sense of well-being, thereby extending the period of life spent in good health11.
Cognitive health also plays a pivotal role in both athletic and professional performance12,13. Maintaining a healthy balance of neurotransmitters, supporting efficient mitochondrial function, and reducing neuroinflammation are essential for stabilizing mood, boosting motivation, and sustaining physical energy. Thus, prioritizing brain health can lead to a happier and more fulfilling life14.
Understanding Brain Health
Definition and importance
Brain health is about optimizing the brain’s ability to function across all dimensions—cognitive, emotional, psychological, and behavioral. When the brain is healthy, it allows for clear thinking, strong memory, balanced emotions, and resilient stress responses. As the body’s command center, the brain governs everything from basic physical actions to complex thought processes, making its health essential for overall well-being and quality of life15.
Cognition, which includes attention, memory, problem-solving, and decision-making, is central to brain health. Memory plays a critical role recalling past experiences and in shaping identity, learning, and day-to-day functioning. Preserving cognitive function is integral to personal and professional success and maintaining independence as we age16,17.
Cognitive decline, dementia, and Alzheimer’s disease
Age-related cognitive decline involves the gradual worsening of cognitive abilities, including memory, attention, decision-making skills, and reasoning, and often signals the early stages of more serious neurodegenerative conditions like Alzheimer’s disease18. Mild cognitive impairment (MCI) is often a bridge between normal age-related cognitive decline and dementia, where early cognitive changes are noticeable but not yet disruptive to daily life19. While some level of cognitive decline is expected with aging, it’s important to recognize the difference between normal aging and more serious conditions like Alzheimer’s disease20. Age-related cognitive decline can be slowed and even partially reversed through lifestyle changes. Engaging in regular physical activity, maintaining a healthy diet rich in antioxidants and omega-3 fatty acids, managing stress, getting adequate sleep, and staying mentally active through learning and social engagement are key strategies in the fight against cognitive decline21.
Alzheimer’s disease, the most common type of dementia, is a progressive neurodegenerative disorder marked by the buildup of amyloid plaques and tau tangles in the brain, leading to brain cell death22. This process typically begins with memory loss and it symptoms progress to include confusion, disorientation, language difficulties, and eventually the inability to perform everyday tasks16.
Dementia is a broad term for conditions that affect memory, cognitive function, and social functioning to the point of interfering with daily life. Alzheimer’s disease accounts for 60-80% of dementia cases, but other forms include vascular dementia, Lewy body dementia, and frontotemporal dementia23. These conditions place significant burdens on individuals, families, and healthcare systems. With an aging population, the burden of care is increasing overall16,17.
Amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and ultimately, respiratory failure. While the exact cause of ALS remains unclear, it is believed to involve a combination of genetic and environmental factors, oxidative stress, and mitochondrial dysfunction24.
A root-cause approach to addressing ALS involves targeting the underlying triggers and supporting overall neurological health, focusing on reducing inflammation, optimizing mitochondrial function, and protecting the body from environmental toxins that may contribute to neurodegeneration. A diet rich in antioxidants and anti-inflammatory foods, such as leafy greens, berries, nuts, and omega-3 fatty acids from fish and flaxseed, helps combat oxidative stress and reduce inflammation in the nervous system25.
Nutrients like CoQ10, alpha-lipoic acid26, and L-carnitine can enhance energy production and protect neurons from damage. Nutrients like glutathione, N-acetylcysteine, and those found in cruciferous vegetables can aid in detoxification27. Specific supplements, such as vitamin D, B vitamins, and magnesium, support nerve health and reduce the risk of neurodegeneration. Vitamin D, in particular, has been linked to neuroprotection and may slow the progression of ALS28.
Parkinson's disease (PD)
Parkinson's disease (PD) is a chronic neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the brain, leading to symptoms such as tremors, stiffness, slowness of movement, and postural instability29. The underlying causes of PD are multifactorial, involving genetic predispositions, environmental exposures, and disruptions to mitochondrial function and oxidative stress30.
A root-cause approach to Parkinson’s disease seeks to reduce oxidative stress, support mitochondrial function, and enhance detoxification while creating an environment in the body that supports brain health and slows disease progression. A diet rich in phytonutrients, particularly from colorful fruits and vegetables, helps combat oxidative stress and inflammation, which are key contributors to neuronal damage in PD31.
Just like in ALS, supporting mitochondrial function is essential in PD32. CoQ10, NAD+, and acetyl-L-carnitine are potent mitochondrial enhancers that can improve energy production and protect brain cells from degeneration. Probiotics, prebiotics, and a fiber-rich diet can contribute to a healthy gut microbiome, which in turn supports brain health and may reduce the progression of PD33. Reducing the body’s toxic burden by supporting liver detoxification with sulfur-rich foods like garlic, onions, and cruciferous vegetables, as well as with supplements like glutathione, plays a vital role in reducing oxidative stress. Nutrients and supplements like vitamin D, omega-3 fatty acids, and curcumin have neuroprotective properties and may also help slow the progression of PD34. These supplements support brain function, reduce inflammation, and enhance overall neurological health.
The role of genetics: family history and genotyping
Genetics plays a crucial role in brain health, impacting both the risk of cognitive decline and the likelihood of developing neurodegenerative diseases like Alzheimer’s disease. While lifestyle factors such as diet, exercise, and mental stimulation are vital for maintaining brain health, genetic predispositions can significantly elevate an individual’s risk for these conditions35.
A strong family history of Alzheimer’s or dementia, particularly in close relatives like parents or siblings, is a clear indicator of genetic risk. This increased risk is often linked to specific gene variants, with the APOE ε4 allele being one of the most recognized36. Carrying one copy of the APOE ε4 gene raises the risk of Alzheimer’s disease, and having two copies amplifies it further. However, having this allele doesn’t guarantee the disease; it simply increases the risk of developing it37.
Genotyping, the process of identifying an individual’s genetic variants, can be a powerful tool in assessing one’s risk. Knowing whether you carry high-risk alleles like APOE ε4 allows for personalized prevention strategies. These approaches may include more rigorous lifestyle interventions, regular cognitive screening, and even participation in clinical trials for preventive therapies38. However, it’s important to approach genetic information with caution. Genetics are just one factor in the complex equation of brain health; environmental influences and lifestyle choices also play significant roles39.
By understanding both genetic and non-genetic factors, individuals can take a proactive approach to brain health. This involves combining lifestyle changes, regular monitoring, and medical interventions when necessary, with the goal of not only delaying or preventing neurodegenerative diseases but also promoting a lifetime of optimal cognitive function and well-being14.
Root Cause Approach to Brain Health
Root causes of cognitive decline
Cognitive decline is a complex, multifactorial process driven by various root causes. Chronic inflammation and oxidative stress are central players, damaging neurons by producing inflammatory cytokines and reactive oxygen species (ROS), which disrupt cellular structures, impair synaptic function, and ultimately lead to neuronal death40. Additionally, the brain’s need for support from factors like brain-derived neurotrophic factor (BDNF) can be compromised by stress, aging, and other conditions, resulting in synaptic loss and cognitive impairment41.
Environmental toxins like heavy metals, pesticides, and mycotoxins (mold toxins) can worsen cognitive decline by impairing mitochondrial function and increasing oxidative stress42. Additionally, glucose dysregulation, especially insulin resistance, impairs the brain’s ability to utilize sugar, leading to energy deficits and cognitive impairment43.
Nutrient deficiencies, particularly in omega-3 fatty acids, B vitamins, and antioxidants, reduce the brain’s ability to synthesize neurotransmitters, weaken defenses against oxidative stress, and promote neurodegeneration44. Hormonal imbalances, including those involving sex hormones like estrogen and testosterone45, insulin46, and thyroid hormones47, can disrupt neuronal communication, increase inflammation, and contribute to cognitive decline.
Vascular damage, such as hypertension and atherosclerosis, significantly impacts cognitive health by restricting blood flow to the brain, depriving it of essential oxygen and nutrients. This may lead to neuronal injury and cognitive impairment48,49. Moreover, a history of head trauma, including repeated concussions or traumatic brain injuries, can disrupt neural networks, leading to chronic neuroinflammation and increased risk of neurodegenerative diseases50.
Trauma-induced cognitive decline resulting from injuries like traumatic brain injuries (TBIs), concussions, and chronic traumatic encephalopathy (CTE) is especially common in athletes, car crash survivors, and veterans. These injuries can lead to memory loss, mood changes, and long-term cognitive impairment, profoundly affecting quality of life51. Repeated head injuries, particularly in contact sports or combat, increase the risk of developing CTE, a progressive brain disease with severe cognitive and emotional consequences.
Inflammation and oxidative stress
Inflammation and oxidative stress are closely linked to cognitive decline. Chronic activation of the brain’s immune cells leads to neuroinflammation, which can cause ongoing damage to neurons52. At the same time, oxidative stress occurs when the brain’s natural antioxidant defenses are overwhelmed by the production of reactive oxygen species (ROS), resulting in mitochondrial dysfunction and cell death53.
These processes can be triggered by infections, toxin exposure, and metabolic imbalances, and are often worsened by poor lifestyle choices like diets high in ultra-processed foods and sugar54. To preserve cognitive function, it’s essential to address the root causes of inflammation and oxidative stress through diet, lifestyle changes, and targeted therapies55.
Nutrient deficiencies
Nutrient deficiencies are a critical yet often overlooked factor in cognitive decline56. The brain depends on a consistent supply of key nutrients like B vitamins, omega-3 fatty acids, vitamin D, and magnesium to function at its best53. When these nutrients are lacking, essential processes like neurotransmitter production, synaptic plasticity, and DNA repair can become compromised55.
For instance, B vitamins are essential for methylation, a process that helps maintain cognitive function and prevents the buildup of homocysteine, a known risk factor for neurodegeneration57,58. Omega-3 fatty acids, especially DHA, are vital for keeping neuronal membranes healthy and supporting anti-inflammatory pathways59. To protect the brain and prevent cognitive decline, it’s important to address nutrient deficiencies through a balanced diet and targeted supplementation55.
Hormonal imbalances
Hormonal imbalances impact cognitive health, especially as we age. Hormones like estrogen, testosterone60, insulin, and thyroid hormones47 play critical roles in regulating brain function.
For instance, a decline in estrogen is linked to a higher risk of neurodegenerative diseases because of its role in protecting neurons and supporting synaptic plasticity61. Insulin resistance, which is common in type 2 diabetes, disrupts the brain’s ability to use glucose efficiently, leading to energy deficits and cognitive impairment62. Additionally, imbalances in cortisol63 and thyroid hormones64 can interfere with neuronal communication and exacerbate inflammation, further contributing to cognitive issues. Maintaining balanced hormone levels through lifestyle changes, proper nutrition, and targeted therapies is crucial for preserving brain health as we age.
Environmental toxins
Exposure to environmental toxins like heavy metals, pesticides, mycotoxins, and industrial chemicals is all too common in today’s world and plays a significant role in cognitive decline by disrupting cellular processes and promoting neuroinflammation54. These toxins can cross the blood-brain barrier, where they accumulate and directly damage neurons, setting the stage for cognitive dysfunction52.
Heavy metals like mercury and lead bind to proteins and disrupt their normal function, leading to neuronal damage65. Pesticides and industrial chemicals further aggravate this damage by interfering with neurotransmitter function and inducing oxidative stress, both of which are key drivers of cognitive decline66.
Mycotoxins, which are toxic compounds produced by certain molds, pose a particularly insidious threat. They can enter the body through inhalation, ingestion, or skin contact, triggering chronic inflammation and oxidative stress6. These toxins can impair mitochondrial function, disrupt hormone signaling, and even damage DNA67. Prolonged exposure to mycotoxins is associated with neurological symptoms like memory loss, brain fog, and cognitive impairment68.
To protect brain health, detoxification is essential. This includes supporting liver function with nutrients like glutathione and N-acetylcysteine, boosting elimination with a diet rich in fiber and antioxidants, and minimizing exposure to known sources of toxins, such as mold-contaminated environments69.
Acute infections
Acute encephalitis can be triggered by various viruses, parasites like Taenia solium (causing neurocysticercosis), and bacteria like Streptococcus pneumoniae. These infections can lead to severe brain inflammation, resulting in cognitive decline, seizures, and long-term neurological damage70. Strengthening the immune system using a nutrient-dense diet and targeted supplements is important for prevention and potential reversal if diagnosed early.
Chronic infections
Chronic infections, such as those caused by herpes simplex virus (HSV), Epstein-Barr virus (EBV), cytomegalovirus (CMV)71, and Chlamydia pneumoniae, are increasingly linked to the development of Alzheimer’s disease72. These pathogens can linger in the body, driving chronic inflammation and activating the brain’s immune system, which leads to neuroinflammation and damage to neurons. HSV-1, in particular, has been found in the brains of individuals with Alzheimer’s disease, where it may interact with genetic factors like the APOE ε4 allele, worsening amyloid plaque buildup and tau pathology73.
Similarly, infections like EBV and CMV are associated with systemic inflammation that can disrupt the blood-brain barrier, allowing harmful molecules and pathogens to enter the brain and contribute to neurodegeneration74. The ongoing presence of these infections may create a pro-inflammatory environment in the brain, increasing the risk and progression of Alzheimer’s disease.
Vascular damage (hypertension, atherosclerosis/arteriosclerosis)
Vascular damage is a key driver of cognitive decline, especially in conditions like hypertension and atherosclerosis. High blood pressure can damage the brain’s delicate blood vessels, leading to microvascular damage and impaired blood flow19. This restricts oxygen and nutrient delivery to brain cells, which can cause neuronal injury and contribute to vascular dementia75.
Atherosclerosis, with its plaque buildup and arterial hardening, further restricts blood flow to the brain, increasing the risk of strokes and other ischemic events that directly damage brain tissue76. The chronic reduction in cerebral blood flow caused by these vascular conditions leads to a gradual but significant decline in cognitive function77.
To protect brain health, it’s crucial to maintain healthy blood pressure, manage cholesterol, and follow a heart-healthy diet to reduce the risk of vascular-related cognitive decline.
History of head trauma
A history of head trauma, especially repeated concussions or traumatic brain injuries (TBIs), is a well-established risk factor for cognitive decline. These injuries can disrupt the brain’s neural networks, leading to chronic neuroinflammation and increased susceptibility to neurodegenerative diseases like Alzheimer's and chronic traumatic encephalopathy (CTE)78.
The damage from head trauma is complex. It can cause immediate damage, such as axonal shearing and brain hemorrhaging, and can also trigger long-term inflammatory responses that worsen neurodegeneration79. TBIs can also hinder the brain’s ability to clear toxic proteins like beta-amyloid and tau, which accumulate and drive cognitive decline50. TBIs can trigger psychological and psychiatric issues, such as depression, anxiety, and mood swings, as the injury alters brain chemistry and disrupts emotional regulation80. For more information, visit Mental Health and Stress Management 101.
TBIs are more severe in women due to differences in brain structure, hormonal fluctuations, and a higher likelihood of post-concussive symptoms like migraines and depression81. The developing brain is particularly vulnerable; in adolescents and children, TBIs can disrupt crucial stages of brain development, leading to long-term cognitive, behavioral, and emotional challenges and impacting their academic performance and social interactions82.
To manage the long-term effects of head trauma, a comprehensive approach is essential. This includes regularly monitoring cognitive function, addressing hormonal imbalances that may arise from pituitary gland injury, and incorporating neuroprotective strategies to support overall brain health.
Lifestyle factors (diet, exercise, sleep, stress)
Lifestyle factors are the cornerstone of brain health, profoundly influencing whether we maintain cognitive function or experience decline. Choose a nutrient-rich, anti-inflammatory diet that’s abundant in whole foods and healthy fats as well as low in sugar. This type of diet provides essential nutrients and reduces oxidative stress, both of which are crucial for optimal brain function.
Regular physical activity is just as vital. Exercise promotes neurogenesis (the creation of new neurons), enhances brain plasticity, and increases the production of growth factors like BDNF that are key to cognitive health83.
Sleep, too, is non-negotiable. It’s during sleep that the brain consolidates memories and clears metabolic waste, including beta-amyloid, the protein associated with Alzheimer’s disease84.
Managing stress is yet another critical element. Chronic stress raises cortisol levels, which can damage the hippocampus, the brain’s memory center. Incorporating practices like meditation, deep breathing, and yoga, as well as working to foster a sense of community, can mitigate stress and protect brain health85.
By addressing these root causes through tailored dietary interventions, lifestyle modifications, detoxification strategies, and improving vascular health and neuroprotection—especially in those with a history of head trauma—we can not only prevent cognitive decline, but also promote brain resilience and longevity35.
Assessing Brain Health
Blood tests
Phosphorylated tau (p-tau)
Phosphorylated tau (p-tau) is a critical biomarker linked to neurofibrillary tangles, one of the key features of Alzheimer’s disease. Elevated p-tau levels in the blood can indicate tau pathology in the brain, making this biomarker especially useful in detecting the disease during the early stages when cognitive decline begins. Measuring p-tau has the potential to identify Alzheimer’s disease even before symptoms appear, offering a diagnostic tool for early detection and even prevention86.
Amyloid beta (Aβ)
Amyloid beta is a protein that forms plaques in the brain, a hallmark of Alzheimer’s disease. The ratio of Aβ42 to Aβ40 in the blood is a vital biomarker for detecting amyloid pathology, especially in the early stages before cognitive symptoms appear. These tests are most effective in the preclinical and early symptomatic phases, making them a valuable tool for early detection and potentially even prevention in those at high risk87.
Amyloid probability score 2 (APS2)
The amyloid probability score 2 (APS2) has high diagnostic accuracy for Alzheimer’s disease, particularly in individuals with mild cognitive impairment or dementia treated in primary care settings. When combined with the percentage of p-tau217, the APS2 significantly enhances diagnostic accuracy. Therefore, when interpreted in the context of mild cognitive symptoms, blood testing to measure APS2 as well as the percentage of p-tau217 ensures timely diagnosis and early intervention. Both are critical to preventing neurodegeneration88.
Neurofilament light chain (NfL)
Neurofilament light chain (NfL) is a key protein found in nerve cells. It is an important marker for brain health. When nerve cells are damaged, NfL is released into the bloodstream or cerebrospinal fluid, making it a valuable means of detecting and monitoring neurological diseases like Alzheimer’s disease, Parkinson’s disease, ALS, frontotemporal dementia, and even acute conditions like traumatic brain injury89. Elevated levels of NfL in the blood or cerebrospinal fluid can indicate ongoing nerve cell damage, even before symptoms appear. This makes NfL a promising biomarker for early diagnosis and for tracking the progression of neurodegenerative diseases90.
Genetic testing
APOE genotype
The APOE gene has different alleles, with APOE ε4 being closely linked to a higher risk of developing Alzheimer’s disease. Genetic testing for the APOE genotype can be a valuable tool for identifying individuals at greater risk, allowing them to take proactive steps in their health management before symptoms emerge. While this test is useful for prevention, it is not typically used to diagnose symptomatic individuals, as it indicates the risk rather than the presence of the disease91.
Point of care tests
Point of care tests allow for rapid, on-site evaluation of traumatic brain injury (TBI) severity, offering immediate insights into whether an individual has sustained significant brain damage92. This is crucial for timely intervention, especially in sports, military, and emergency settings. Measuring specific biomarkers in the blood, such as neurofilament light chain (NfL)89 or glial fibrillary acidic protein (GFAP)93, can help guide treatment decisions, monitor recovery, and potentially prevent long-term cognitive decline.
Other tests
Inflammatory markers (e.g., C-reactive protein, IL-6)
Inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6) are indicators of systemic inflammation, which is linked to cognitive decline and neurodegenerative diseases94. These tests are useful for both prevention and monitoring because chronic inflammation is a significant risk factor for cognitive impairment. Addressing inflammation early can delay or even prevent the onset of cognitive symptoms.
Nutrients (e.g., Vitamin D, B vitamins, omega-3 fatty acids)
Assessing nutrient levels, especially levels of vitamin D, B vitamins, and omega-3 fatty acids, is essential for identifying deficiencies that may contribute to cognitive decline95. By addressing these deficiencies early, it helps to support cognitive function and significantly lower the risk of neurodegenerative diseases. Regular testing and monitoring are key strategies in maintaining optimal brain health and preventing cognitive issues.
Metabolic function (e.g., glucose, insulin, HbA1c)
Metabolic markers such as fasting glucose, insulin, and HbA1c (a marker of long-term blood sugar control), are essential for evaluating insulin resistance and diabetes, both of which are key risk factors for cognitive decline and Alzheimer’s disease. Monitoring these markers is critical in both the prevention and early symptomatic stages of cognitive decline, as maintaining healthy blood sugar levels can significantly reduce the risk of cognitive impairment and help slow the progression of the disease96.
Heavy metals (e.g., lead, mercury)
Heavy metals like lead and mercury can build up in the body, leading to neurotoxicity and cognitive decline65. Mercury is particularly harmful because it can cross the blood-brain barrier; once it is in the brain, it damages neurons and disrupts brain function97. This buildup is linked to memory problems, difficulty concentrating, and an increased risk of neurodegenerative diseases like Alzheimer’s disease.
Detoxifying the body through dietary changes, supplements, and reducing exposure to heavy metals is crucial for protecting brain health. By testing blood or urine for these toxins, we can identify overall exposure levels. This is particularly relevant for prevention, as minimizing exposure and supporting the body’s detoxification processes can protect against cognitive issues.
Infections
When it comes to infections that can cause significant cognitive damage, certain viruses, parasites, and bacteria are particularly concerning.
- Viruses: Viruses like herpes simplex virus (HSV), West Nile virus, and Japanese encephalitis virus are known to cause encephalitis (inflammation of the brain) that can lead to severe neurological symptoms, including memory loss, confusion, and cognitive decline98.
- Parasites: Cysticercosis, caused by the Taenia solium tapeworm, is one of the leading parasitic infections impacting the brain. When the larvae invade the central nervous system, it can result in neurocysticercosis, causing seizures, headaches, and cognitive impairments99.
- Bacteria: Bacterial infections like meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae can also result in cognitive damage100. These bacteria can cause inflammation of the brain, resulting in long-term cognitive deficits like memory problems and difficulty concentrating.
Understanding the underlying causes makes it possible to implement strategies to boost the immune system, support detoxification, and ensure the body can effectively combat these infections.
Mycotoxins
Mycotoxins, which are toxic substances produced by molds, can cause significant neurological harm, contributing to cognitive decline101. Identifying exposure early, typically through urine analysis, is key to prevention. Once detected, targeted detoxification strategies can help reduce their impact and protect brain health.
Autoimmune markers (e.g., ANA, rheumatoid factor)
Autoimmune markers like antinuclear antibodies (ANA) and rheumatoid factor (RF) can indicate the presence of autoimmune diseases, which are often linked to cognitive decline through systemic inflammation102,103. Identifying these biomarkers early is valuable in both the prevention and symptomatic stages, as it allows for timely intervention to manage autoimmune activity. By addressing the underlying inflammation, we can protect brain health and potentially slow cognitive decline in those affected.
Function tests
- Beta-amyloid 42/40 ratio: Assesses risk of Alzheimer’s disease pathology in adults with mild cognitive impairment (MCI) or dementia.
- Phosphorylated tau (p-tau): Assesses Alzheimer’s disease-associated tau pathology in adults with mild cognitive impairment (MCI) or dementia.
- Apolipoprotein E (ApoE) genotype: ApoE is a predictive genetic biomarker that can determine the risk of developing AD before symptom onset.
- High-sensitivity C-reactive protein (hs-CRP): Assesses systemic inflammation that can influence brain health104.
- Advanced lipid biomarker assessment: Helps in assessing the risk of cardiovascular diseases more accurately than a standard lipid panel, and includes total cholesterol/HDL ratio, HDL large, LDL cholesterol, LDL particle number, LDL peak size, Lipoprotein (a), total cholesterol, Apolipoprotein B (ApoB), HDL cholesterol, LDL medium, LDL pattern, LDL small, Non-HDL cholesterol, triglycerides.
- Metabolic : Helps identify metabolic derangements such as insulin resistance and diabetes, which are risk factors for cognitive decline and AD, and includes adiponectin, glucose, hemoglobin A1c (HbA1c), insulin, leptin, and uric acid in serum.
- Nutrients: Essential for brain health and cognitive function.
- Vitamin D, 25-hydroxy: Important for brain health and neuroprotection105.
- Omega-6/Omega-3 ratio: Essential fatty acids that play a role in reducing inflammation and supporting neuronal function.
- Homocysteine: Elevated levels can be a risk factor for cognitive decline95.
- Tick (Lyme) antibodies: Checks for antibodies related to the tick-borne disease.
- Viral antibodies: These include cytomegalovirus antibodies (IgG, IgM), Epstein-Barr virus antibody (IgG, IgM), Epstein-Barr virus early antigen D antibody (IgG), hepatitis panel, and herpesvirus 6 (HHV-6) antibodies.
- Thyroid (thyroglobulin antibodies, thyroid peroxidase antibodies, TSH, free T4, free T3): Ensures thyroid hormones are balanced, as imbalances can affect cognitive health106.
- Cortisol: Checks for stress and adrenal function, which can impact overall health and brain function107.
- Liver (ALP, ALT, AST, GGT, total bilirubin, total protein): Assesses liver health, as liver function can impact overall metabolism and brain health.
- Kidney (BUN, BUN/creatinine ratio, blood creatinine, urine creatinine, eGFR, microalbumin, sodium): Checks kidney health, which is essential for maintaining metabolic balance.
Nutrition and Supplements for Brain Health
Nutrition plays a key role in overall health. Nutrition 101 is a science-based review of foundational nutritional principles and eating practices that promote health and well-being.
The MIND (Mediterranean-DASH diet Intervention for Neurodegenerative Delay) diet
The MIND diet emphasizes whole foods, healthy fats, and plant-based nutrients and while limiting the intake of animal products and high saturated-fat foods108. Key components include:
- Green leafy vegetables: 6+ servings/week
- Vegetables: 1+ servings/day
- Berries: 2+ servings/week
- Nuts: 5+ servings/week
- Whole grains: 3+ servings/day
- Beans: 3+ meals/week
- Fish: 1+ meals/week
- Poultry: 2+ meals/week
- Olive oil
The MIND diet includes foods rich in folate, vitamin E, carotenoids, and flavonoids, the antioxidant and anti-inflammatory properties of which protect the brain by reducing oxidative stress and neuroinflammation109.
Mediterranean ketogenic diet
The Mediterranean ketogenic diet (MKD) combines the principles of the Mediterranean and ketogenic diets, offering a powerful dietary approach rich in healthy fats from fish, nuts, seeds, and olive oil110. This diet emphasizes a higher intake of polyunsaturated and monounsaturated fats known for their anti-inflammatory and neuroprotective properties111. Unlike the standard ketogenic diet, which often emphasizes saturated fats from sources like red meat and dairy, the MKD focuses on omega-3 fatty acids from fish and alpha-linolenic acid from plants. These fats are essential for protecting brain health, reducing oxidative stress, and lowering inflammation—key factors in preventing and managing Alzheimer’s disease112.
The MKD’s emphasis on anti-inflammatory and antioxidant-rich foods, like those found in the Mediterranean diet, offers significant advantages for cognitive health113. While the standard ketogenic diet effectively promotes ketosis and reduces carbs, it can also lead to increased intake of saturated fats, potentially increasing inflammation if not carefully balanced with other nutrients114. In contrast, the MKD’s focus on healthy fats and plant-based nutrients like polyphenols supports brain function, reduces neuroinflammation, and may provide superior protection against Alzheimer’s disease115,116.
Anti-inflammatory diet
Chronic inflammation is linked to increased accumulation of beta-amyloid plaques and tau tangles in the brain. An anti-inflammatory diet helps reduce inflammation and supports brain health. Adopting a diet rich in anti-inflammatory foods can mitigate Alzheimer’s brain pathology. These foods include:
- Fruits and vegetables: Rich in antioxidants, vitamins, and minerals. Berries, leafy greens (e.g., collard greens, kale, spinach, Swiss chard), and cruciferous vegetables are particularly beneficial117.
- Healthy fats: Omega-3 fatty acids found in fatty fish (such as salmon, mackerel, and sardines), ground flaxseed, chia seeds, and walnuts can reduce inflammation and support neuronal health118.
- Whole grains: Foods like quinoa, brown rice, and oats provide essential nutrients and fiber, supporting overall health and reducing inflammation119.
- Nuts and seeds: Almonds, chia seeds, and sunflower seeds provide healthy fats and antioxidants that can protect brain cells120.
- Olive oil: A primary fat source in the Mediterranean diet, olive oil is rich in monounsaturated fats and antioxidants121,122
- Curcumin: The active ingredient in turmeric, curcumin has powerful anti-inflammatory and antioxidant properties123.
Antioxidant-rich foods
Antioxidants neutralize free radicals that can damage brain cells and contribute to the accumulation of beta-amyloid plaques and tau tangles in the brain.
- Berries: Blueberries, strawberries, and blackberries are high in antioxidants and may improve cognitive function124,125.
- Green tea: Has neuroprotective effects126.
- Dark chocolate: Contains flavonoids that can enhance brain function and reduce oxidative stress127,128.
The gut-friendly diet: foods that promote microbiome wellness
A healthy gut microbiome supports brain health129. To feed the microbiome, incorporate:
- Fermented food: Yogurt and kefir (if dairy is tolerated), sauerkraut, and kimchi.
- High-fiber foods: Cruciferous vegetables, whole grains, beans, and legumes.
Key supplements for brain health
Omega-3 fatty acids (EPA and DHA)
Omega-3 fatty acids, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential for maintaining the structure and function of brain cells. DHA is a critical component of effective communication between neurons130. EPA, on the other hand, is vital for reducing inflammation, which protects the brain from chronic conditions that can lead to cognitive decline131. Together, EPA and DHA enhance cognitive function, support synaptic plasticity, and may lower the risk of neurodegenerative diseases like Alzheimer’s132.
- Benefits: Improves cognitive function and reduces inflammation133
- Dose: 1-3 g.
- Frequency: Once daily.
- Mechanism of action: Reduce inflammation by inhibiting the production of pro-inflammatory cytokines and modulating membrane fluidity in neurons.
B vitamins (B6, B12, folate)
B vitamins—specifically B6, B12, and folate—are vital for brain health because they play a key role in managing homocysteine levels. Elevated homocysteine is linked to a higher risk of cognitive decline and Alzheimer’s disease58. B vitamins help convert homocysteine into methionine, effectively lowering its levels and supporting brain function. They are also involved in neurotransmitter synthesis, DNA repair, and myelin formation, all critical processes for preserving cognitive function and protecting against neurodegeneration. B vitamin supplementation reduces oxidative stress and may lower the risk of neurodegenerative diseases over time134.
When supplementing with B vitamins, it’s important to choose the correct methylated forms, such as pyridoxal‑5‑phosphate instead of B6, methylcobalamin instead of hydroxocobalamin, and 5 methyl-folate instead of folate, as they are more bioavailable and can be better utilized by the body, especially for those with genetic variations affecting methylation135.
Vitamin B6 (pyridoxal‑5‑phosphate)
- Benefits: Supports neurotransmitter synthesis essential for cognitive function136.
- Dose: 2-10 mg.
- Frequency: Daily as part of a multivitamin.
- Mechanism of action: B6 acts as a cofactor for enzymes involved in amino acid metabolism, neurotransmitter synthesis, and conversion of homocysteine, supporting neurological health.
Vitamin B12 (methylcobalamin)
- Benefits: Essential for myelin formation, protecting nerve fibers and supporting cognitive function95.
- Dose: 2.4 mcg.
- Frequency: Daily as part of a multivitamin.
- Mechanism of action: B12 is vital in the methylation cycle, converting homocysteine to methionine, and is critical for DNA synthesis.
Folate (5 methyl- folate)
- Benefits: Converts homocysteine to methionine, supports neurotransmitter synthesis and DNA repair137
- Dose: 400-800 mcg.
- Frequency: Daily as part of a multivitamin.
- Mechanism of action: Folate is crucial for DNA and RNA synthesis and for the conversion of homocysteine to methionine.
Vitamin D
Vitamin D plays a vital role in brain health through its neuroprotective, anti-inflammatory, and antioxidant properties. It also plays a key role in regulating the immune system and reducing neuroinflammation, both of which are linked to cognitive decline and dementia138.
Vitamin D receptors are present throughout the brain, suggesting that adequate levels of this vitamin are crucial for maintaining cognitive function139. A deficiency in vitamin D has been associated with a higher risk of cognitive impairment and Alzheimer’s disease, highlighting the need for supplementation, especially in older adults140.
- Benefits: Supports overall brain health and reduces risk of cognitive decline105.
- Dose: 1,000-2,000 IU.
- Frequency: Once daily.
- Mechanism of action: Regulates neurotrophic factors and reduces neuroinflammation.
Magnesium
Magnesium is crucial for many brain functions, including neurotransmitter release, synaptic plasticity, and protecting neurons. It also helps regulate NMDA receptors, which are key to learning and memory. Low magnesium levels have been linked to increased oxidative stress, inflammation, and a higher risk of neurodegeneration141. Maintaining adequate magnesium levels supports cognitive function, helps reduce anxiety, and may protect against age-related cognitive decline142.
- Benefits: Magnesium helps protect against neurodegeneration by reducing oxidative stress and inflammation141.
- Dose: 200-400 mg/day.
- Frequency: Once daily.
- Mechanism of action: Reduces oxidative stress, which protects neurons from damage and slows the progression of neurodegenerative diseases.
Curcumin
Curcumin, the active compound in turmeric, has strong anti-inflammatory and antioxidant effects that are beneficial for brain health143. It can cross the blood-brain barrier, reducing neuroinflammation and oxidative stress—both major factors in cognitive decline and neurodegenerative diseases like Alzheimer’s disease144. Curcumin has also been shown to lower amyloid plaque buildup and tau protein aggregation in the brain, making it a promising nutraceutical for supporting cognitive function and potentially preventing Alzheimer’s disease145.
- Benefits: Potent anti-inflammatory and antioxidant properties123,145.
- Dose: 500-1,000 mg.
- Frequency: Once daily.
- Mechanism of action: By inhibiting the activity of inflammatory enzymes and reducing oxidative stress, curcumin reduces amyloid and tau accumulation in the brain, both of which are associated with Alzheimer’s disease and other forms of dementia.
Phosphatidylserine
Phosphatidylserine is a vital phospholipid found in brain cell membranes, playing a crucial role in maintaining cellular health, aiding neurotransmitter release, and supporting synaptic plasticity146. Supplementing with phosphatidylserine has been shown to enhance memory, cognitive function, and mood, especially in older adults. It may also help slow cognitive decline by preserving brain cell membrane integrity and improving communication between neurons147.
- Benefits: Supports cognitive function and memory148.
- Dose: 100-300 mg.
- Frequency: Once daily.
- Mechanism of action: Modulates neurotransmitter release and synaptic function.
Ginkgo biloba
Ginkgo biloba is a powerful herbal supplement that’s been trusted for centuries to boost brain health. It works by improving blood flow to the brain, ensuring that brain cells receive the oxygen and nutrients they need to thrive. Ginkgo is also rich in antioxidants, which help protect your brain cells from oxidative damage and reduce inflammation149. Ginkgo biloba is also associated with improved memory, attention, and overall cognitive function, especially in those with mild cognitive impairment or early-stage Alzheimer’s disease150.
- Benefits: Enhances cognitive function and improves blood flow to the brain151.
- Dose: 120-240 mg.
- Frequency: Once daily.
- Mechanism of action: Ginkgo biloba increases cerebral blood flow and has neuroprotective antioxidant properties.
Coenzyme Q10 (CoQ10)
Coenzyme Q10 (CoQ10) is a powerful antioxidant that plays a crucial role in mitochondrial energy production, which is essential for brain health. It helps protect neurons from oxidative damage and supports overall cognitive function, making it particularly valuable in conditions like Parkinson’s disease and Alzheimer’s disease, in which mitochondrial dysfunction is a key factor152.
- Benefits: CoQ10 is an antioxidant that supports mitochondrial function and reduces oxidative stress153.
- Dose: 100-300 mg.
- Frequency: Once daily.
- Mechanism of action: Improves mitochondrial function and reduces oxidative stress, which can help in lowering tau phosphorylation.
Alpha-lipoic acid (ALA)
Alpha-lipoic acid (ALA) is a potent antioxidant that supports brain health by protecting neurons from oxidative stress and inflammation, both of which are key factors in neurodegenerative diseases. It also enhances mitochondrial function, promoting energy production in brain cells and potentially slowing cognitive decline154.
- Benefits: Antioxidant properties improve mitochondrial function155.
- Dose: 600 mg.
- Frequency: Once daily.
- Mechanism of action: Reduces oxidative stress and inflammation.
Acetyl-L-carnitine
Acetyl-L-carnitine (ALC) is a naturally occurring compound that plays a crucial role in energy production by transporting fatty acids into the mitochondria, where they are burned for fuel. In the brain, ALC supports cognitive function and neuroprotection by enhancing mitochondrial function, reducing oxidative stress, and promoting the synthesis of the neurotransmitter acetylcholine, which is vital for memory and learning156.
- Benefits: Enhances cognitive function and energy production156.
- Dose: 500-2,000 mg.
- Frequency: Once daily.
- Mechanism of action: Facilitates mitochondrial energy production and has neuroprotective effects.
Lifestyle Factors
Importance of sleep
Maintaining good sleep quality is essential for overall health and particularly important for brain health. For more information, visit Sleep 101.
Especially in midlife, poor sleep is associated with an increased risk of developing dementia later in life. Restorative sleep reduces the production of proinflammatory cytokines and regulates inflammation, reduces stress, and improves blood flow to the brain. During sleep, the heart rate and blood pressure naturally decrease, allowing the brain to rest and recover from daily activities. Over time, this reduces risk of cognitive decline.
Slow-wave sleep (SWS), the deepest stage of non-REM sleep, is particularly important for memory consolidation and the clearance of metabolic waste products from the brain157. The accumulation of amyloid-beta plaques and tau tangles in the brain are central features of neurodegeneration and cognitive decline in Alzheimer’s disease and other forms of dementia22.
The glymphatic system, a network in the brain responsible for clearing waste products like amyloid-beta and tau proteins, is most active during sleep, particularly deep sleep. Disrupted or insufficient SWS contributes to the accumulation of amyloid-beta and tau proteins by impairing the brain’s ability to clear these proteins, accelerating the progression of neurodegenerative conditions158.
Improving sleep quality—specifically, increasing the amount of SWS—is a key strategy in delaying or preventing the onset of neurodegenerative diseases. Interventions aimed at increasing SWS, such as acoustic stimulation during sleep, lifestyle modifications, and potential pharmacological approaches, are protective against cognitive decline and dementia157.
Additionally, elevated cortisol levels, often associated with chronic stress and sleep disturbances, may contribute to an increased risk of beta-amyloid accumulation in the brain over time. This accumulation is a hallmark of Alzheimer’s disease and managing cortisol levels is critical for preventing or slowing the progression of Alzheimer's disease159
Notably, sleep disorders such as obstructive sleep apnea (OSA) may increase the risk for Alzheimer’s disease by interfering with blood flow to the brain and disrupting brain patterns that promote cognitive health160.
Exercise
Regular exercise benefits overall health by improving cardiovascular health, aiding in weight management, lowering blood pressure, and reducing the risk of conditions such as hypertension. For more detailed information on exercise, including how to adapt exercise for disability, visit Exercise 101.
Regular aerobic exercise is a powerful tool in slowing the progression of Alzheimer’s disease161. It not only supports brain health by improving blood flow, reducing inflammation, promoting upregulation of neurotrophic factors such as BDNF162,163, and increasing neurogenesis (the growth of new neurons), but it also aids in managing weight, lowering blood pressure, and reducing the risk of chronic metabolic conditions like obesity, diabetes, and cardiovascular disease—key risk factors for Alzheimer’s disease164.
Exercise has neuroprotective effects for diabetes-related neurodegenerative conditions because it improves insulin sensitivity and blood sugar control, and reduces inflammation165,166. Moderate- to high-intensity aerobic exercise has been shown to enhance learning and memory, making it a crucial component of any strategy to maintain cognitive health as we age167,168.
In neurodegenerative conditions like Parkinson’s disease, exercise lowers elevated hs-CRP levels, improves mitochondrial function169,170 and has positive effects on the gut microbiome, leading to improvements in cognitive function and mood as well as reduced disease risk3,171. Additionally, mind-body exercises like Tai Chi, yoga, and meditation improve cognitive function, sleep quality, disease symptoms, and quality of life in individuals with Parkinson’s disease172.
The role of social connection in cognitive health
Social connection is a vital component of cognitive health, especially as we age. Engaging in meaningful social interactions helps stimulate cognitive function, reducing the risk of cognitive decline and neurodegenerative diseases like Alzheimer’s disease161. Social connection promotes the release of neurotransmitters like dopamine and serotonin, which are essential for mood regulation and brain health173. Additionally, social engagement provides mental stimulation, emotional support, and a sense of purpose—all of which contribute to maintaining cognitive function. Individuals who maintain strong social ties are more likely to experience slower cognitive decline and have a lower risk of dementia.
Strategies to help maintain social engagement to support cognitive health174,175:
- Involvement in group activities: Encourage participation in group activities like art classes, music therapy, or gardening, which can provide both mental stimulation and a sense of community.
- Regular family visits: Arrange frequent, structured visits from family members to provide familiarity and emotional support.
- Utilize technology: Use video calls to connect with distant friends and family, helping to maintain relationships even when physical visits aren’t possible176.
- Engage in community programs: Involvement in community programs tailored to those with Alzheimer’s, such as memory cafes or senior centers, can foster a supportive social environment.
- Volunteer opportunities: Provide opportunities for volunteering in safe and supervised settings, allowing individuals to contribute to their community while staying engaged.
- Pet therapy: Interaction with pets can provide comfort, reduce stress, and create opportunities for socialization, particularly in group settings where multiple individuals can interact with the animals.
- Encourage reminiscence therapy: Sharing personal stories and memories in a group setting can enhance social bonds and provide cognitive stimulation through discussion.
Navigating Alzheimer’s disease: the social and family impact of cognitive decline and caregiver stress
Mental health and stress reduction are paramount for overall well-being, including brain health. Visit Mental Health and Stress Management 101 for more information on optimizing mental health and managing stress.
Alzheimer’s disease affects more than just the individual who has the condition; it has far-reaching consequences for families and caregivers177. The emotional, physical, and financial tolls of caregiving can lead to chronic stress, burnout, and health challenges for those providing care. By focusing on modifiable risk factors for cognitive decline, we can improve outcomes for those at risk and reduce the heavy burden on caregivers and families. Access to community support, education, and resources is crucial in managing the widespread impact of cognitive disorders178.
A root-cause approach to prevention
A root cause approach is aimed at preventing and reversing cognitive decline and dementia associated with Alzheimer’s disease, mild cognitive impairment (MCI), and other neurodegenerative conditions179.
This typically involves a multifaceted approach that includes a series of tests and protocols to identify and address the underlying causes of cognitive impairment:
Testing
Comprehensive blood tests: These tests provide a broad view of an individual’s health and help identify any underlying conditions contributing to cognitive decline.
- Nutrient deficiencies: Assess levels of vitamin D, B12, folate, magnesium, and omega-3 fatty acids. These nutrients are crucial for brain health and cognitive function. Deficiencies can lead to neurological symptoms and impaired cognitive performance140.
- Inflammation: High-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), and homocysteine are markers of inflammation. Chronic inflammation is linked to neurodegenerative diseases, and these markers help assess the body’s inflammatory status180.
- Infectious pathogens: Viruses and other common pathogens may trigger chronic inflammation and immune system disturbances affecting brain health181. Commonly tested pathogens include herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), Borrelia burgdorferi (associated with Lyme disease), Bartonella species (associated with cat scratch disease and other conditions), Mycoplasma pneumoniae, Chlamydia pneumoniae, and Helicobacter pylori.
- Metabolic: Fasting glucose, insulin, HbA1c, lipid profile (including advanced lipid testing) paint a picture of metabolic health. Metabolic health impacts brain function, and markers like glucose and insulin resistance are associated with cognitive decline62.
- Thyroid: These include TSH, free T3, free T4, reverse T3, and thyroid antibodies. Thyroid hormones are essential for brain development and function; imbalances can contribute to cognitive issues64.
- Hormones: These include estradiol, progesterone, testosterone, DHEA-S, and sex hormone-binding globulin (SHBG). These hormones influence brain function, mood, and cognition, and imbalances can affect cognitive health182.
- Stress and againg: This is measured through testing for cortisol (via saliva or urine) and DHEA. Adrenal hormones regulate stress response, and chronic stress can negatively impact cognitive function183.
Genetic testing: Identifies genetic predispositions that can influence cognitive decline and the effectiveness of various interventions.
- ApoE genotyping: To determine genetic risk for Alzheimer’s disease (AD). The APOE E4 allele is a significant genetic risk factor for late-onset AD184.
- Other relevant genes: MTHFR (Methylenetetrahydrofolate reductase) and other genes involved in detoxification and methylation pathways. These genes affect neurochemical processes and detoxification, impacting cognitive health185.
Toxin exposure testing: Identifies environmental toxins that can contribute to cognitive decline.
- Heavy metals: Mercury, lead, arsenic, and aluminum levels via blood or urine. Heavy metal toxicity is linked to neurological damage and cognitive impairment186.
Gut health assessment: The gut-brain axis is a dynamic communication network that links the gut and brain, playing a pivotal role in maintaining overall brain health. An imbalance in gut bacteria can lead to inflammation and disruptions in neurotransmitter production, contributing to conditions like anxiety, depression, and even neurodegenerative diseases189.
- Comprehensive stool analysis: Evaluates gut microbiota, digestion, absorption, inflammation, and presence of pathogens. Gut health significantly impacts brain function through the microbiota-gut-brain axis190.
- Leaky gut markers: Levels of zonulin and lipopolysaccharides (LPS) may indicate increased intestinal permeability, which can lead to systemic inflammation and affect brain health191.
Advanced neurocognitive testing: Provides detailed information on cognitive function and brain structure.
- Neuropsychological tests: Assess cognitive function, memory, executive function, and other cognitive domains. These tests help determine the extent of cognitive impairment.
- Brain imaging: MRI or PET scans to evaluate structural and functional brain changes can reveal brain atrophy, amyloid plaques, and other signs of cognitive decline193.
Other root cause tests: Identifies underlying biochemical and physiological factors contributing to cognitive decline.
- Oxidative stress markers: These include 8-OHdG, F2-isoprostanes. Oxidative stress is a major factor in neurodegenerative diseases and cognitive decline194.
- Mitochondrial function: These include levels of lactate, pyruvate, and CoQ10. Mitochondrial dysfunction can lead to decreased energy production and increased oxidative stress, affecting brain function195.
- Inflammatory cytokines: IL-6, TNF-alpha, and other pro-inflammatory cytokines can assess inflammation levels. Chronic inflammation is linked to cognitive decline and neurodegeneration180.
Protocols
Personalized nutrition plan: Tailored to the individual’s specific health needs, this plan emphasizes dietary changes to support brain health and overall wellness.
- Anti-inflammatory diet: Focus on whole, nutrient-dense foods rich in antioxidants and healthy fats, such as those found in the Mediterranean diet. This diet is known to reduce inflammation and oxidative stress, which are key factors in cognitive decline25.
- Ketogenic or MIND diet: Depending on individual needs, these diets support brain health and reduce neuroinflammation. The ketogenic diet provides ketones as an alternative energy source for the brain, while the MIND diet combines elements of the Mediterranean and DASH diets to lower the risk of Alzheimer’s disease108.
- Elimination diet: Identifying and removing food sensitivities and allergens can reduce systemic inflammation and improve cognitive function. Common culprits include gluten, dairy, and soy, among others.
Targeted supplementation: Supplements are chosen based on specific deficiencies and health goals to optimize cognitive function.
- Nutrient repletion: Vitamins D, B12, B-complex, magnesium, omega-3 fatty acids, and other essential nutrients are supplemented to address deficiencies and support brain health196.
- Antioxidants: CoQ10, alpha-lipoic acid, N-acetyl cysteine (NAC), and glutathione are used to combat oxidative stress and protect neuronal integrity.
- Brain-specific nutrients: Phosphatidylserine, acetyl-L-carnitine, curcumin, resveratrol, and Bacopa monnieri can enhance neuroprotection, improve memory, and reduce neuroinflammation148,156,197.
Hormonal balance: Optimal levels of hormones are critical for cognitive health and overall well-being.
- Bioidentical hormone replacement therapy (BHRT): Used to optimize sex hormone levels (estrogen, progesterone, testosterone) as well as thyroid and adrenal function, which can influence cognitive function and mood198.
- Stress reduction techniques: Mindfulness, meditation, yoga, and other stress management practices can lower cortisol levels and improve mental clarity199.
Detoxification protocols: Designed to eliminate toxins that may contribute to cognitive decline and other health issues.
- Detox support: Supplements like glutathione and NAC, along with binders such as activated charcoal or bentonite clay and sauna therapy to enhance the body’s detoxification processes200.
- Gut health restoration: Using probiotics, prebiotics, digestive enzymes, and gut-healing nutrients like L-glutamine and zinc carnosine to restore gut integrity and balance the microbiome190.
Lifestyle interventions: Essential changes in daily habits that support cognitive health and overall wellness.
- Exercise: Regular aerobic and strength-training exercises improve cardiovascular health, stimulate neurogenesis, and enhance brain plasticity201.
- Sleep optimization: Improving sleep hygiene and addressing sleep disorders to ensure restorative sleep, which is vital for cognitive function and overall health202.
- Cognitive training: Engaging in activities that challenge the brain, such as puzzles, learning new skills, and social engagement, to enhance cognitive reserve and delay cognitive decline203.
Ongoing monitoring and adjustments: Continuous evaluation and support to ensure the effectiveness of the treatment plan.
- Regular follow-up visits: Monitoring progress and making necessary adjustments to the treatment plan based on individual response and changing needs.
- Continuous education and support: Empowering individuals with knowledge and resources to take an active role in their health journey and maintain long-term cognitive health.
This is a comprehensive and individualized approach, addressing the unique needs of each individual to slow or reverse cognitive decline and dementia through comprehensive diagnostics and tailored interventions. A root cause approach aims to improve and potentially reverse the symptoms of cognitive impairment by integrating a suite of science-based strategies that include dietary changes, lifestyle modifications, targeted supplements, and environmental detoxification.
1. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota's effect on mental health: The gut-brain axis. Clinics and practice. Sep 15 2017;7(4):987. doi:10.4081/cp.2017.987
2. Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life sciences. Jan 1 2021;264:118627. doi:10.1016/j.lfs.2020.118627
3. Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. npj Parkinson's Disease. 2021/03/10 2021;7(1):27. doi:10.1038/s41531-021-00156-z
4. Bonnechère B, Amin N, van Duijn C. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review. International Journal of Molecular Sciences. 2022;23(22):13665.
5. Nabi M, Tabassum N. Role of Environmental Toxicants on Neurodegenerative Disorders. Frontiers in toxicology. 2022;4:837579. doi:10.3389/ftox.2022.837579
6. Zhang Z. Mycotoxin OTA Triggers Alzheimer's Disease. presented at: Proceedings of the 3rd International Symposium on Artificial Intelligence for Medicine Sciences; 2022; Amsterdam, Netherlands. https://doi.org/10.1145/3570773.3570835
7. Song S, Stern Y, Gu Y. Modifiable lifestyle factors and cognitive reserve: A systematic review of current evidence. Ageing research reviews. Feb 2022;74:101551. doi:10.1016/j.arr.2021.101551
8. Harvey A. Friedman Center for Aging. Healthspan is more important than lifespan, so why don’t more people know about it? Washington University in St. Louis, Institute for Public Health; May 30, 2017. https://publichealth.wustl.edu/heatlhspan-is-more-important-than-lifespan-so-why-dont-more-people-know-about-it/
9. Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain, behavior, and immunity. Feb 2017;60:1-12. doi:10.1016/j.bbi.2016.03.010
10. Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Van Giau V. Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease. International Journal of Molecular Sciences. 2020;21(9):3165.
11. Bodai Balazs I, Nakata Therese E, Wong William T, et al. Lifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival. The Permanente Journal. 2018/03/01 2018;22(1):17-025. doi:10.7812/TPP/17-025
12. Erickson KI, Hillman C, Stillman CM, et al. Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines. Medicine and science in sports and exercise. Jun 2019;51(6):1242-1251. doi:10.1249/mss.0000000000001936
13. Müller P, Stiebler M, Schwarck S, Haghikia A, Düzel E. Physical Activity, Aging and Brain Health. Deutsche Zeitschrift für Sportmedizin. 11/01 2021;Volume 72(No. 7):327-334. doi:10.5960/dzsm.2021.506
14. Mintzer J, Donovan KA, Kindy AZ, Lock SL, Chura LR, Barracca N. Lifestyle Choices and Brain Health. Review. Frontiers in Medicine. 2019;6
15. Morley JE, Morris JC, Berg-Weger M, et al. Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. Journal of the American Medical Directors Association. Sep 1 2015;16(9):731-9. doi:10.1016/j.jamda.2015.06.017
16. Hilal S, Brayne C. Epidemiologic Trends, Social Determinants, and Brain Health: The Role of Life Course Inequalities. Stroke. Feb 2022;53(2):437-443. doi:10.1161/strokeaha.121.032609
17. Avan A, Hachinski V. Brain health: Key to health, productivity, and well-being. Alzheimer's & dementia : the journal of the Alzheimer's Association. Jul 2022;18(7):1396-1407. doi:10.1002/alz.12478
18. Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clinics in geriatric medicine. Nov 2013;29(4):737-52. doi:10.1016/j.cger.2013.07.002
19. Gorelick PB, Furie KL, Iadecola C, et al. Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association. Stroke. 2017/10/01 2017;48(10):e284-e303. doi:10.1161/STR.0000000000000148
20. Randhawa SS VD. Geriatric Evaluation and Treatment of Age-Related Cognitive Decline. StatPearls [Internet]. StatPearls Publishing; 2023. Updated September 28, 2023. https://www.ncbi.nlm.nih.gov/books/NBK580536/
21. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet (London, England). Jun 6 2015;385(9984):2255-63. doi:10.1016/s0140-6736(15)60461-5
22. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England). Aug 8 2020;396(10248):413-446. doi:10.1016/s0140-6736(20)30367-6
23. Duong S, Patel T, Chang F. Dementia: What pharmacists need to know. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. Mar-Apr 2017;150(2):118-129. doi:10.1177/1715163517690745
24. van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. The Lancet. 2017;390(10107):2084-2098. doi:10.1016/S0140-6736(17)31287-4
25. Scheiber A, Mank V. Anti-Inflammatory Diets. StatPearls [Internet]. StatPearls Publishing; October 28, 2023; 2023. Accessed August 17, 2024. https://pubmed.ncbi.nlm.nih.gov/37983365/
26. Viana MDM, Lauria PSS, Lima AA, Opretzka LCF, Marcelino HR, Villarreal CF. Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain. Antioxidants (Basel, Switzerland). Dec 8 2022;11(12)doi:10.3390/antiox11122420
27. Raghu G, Berk M, Campochiaro PA, et al. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Current neuropharmacology. 2021;19(8):1202-1224. doi:10.2174/1570159x19666201230144109
28. Lương K, Nguyễn LT. Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms. Molecular brain. Apr 9 2013;6:16. doi:10.1186/1756-6606-6-16
29. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nature Reviews Disease Primers. 2017/03/23 2017;3(1):17013. doi:10.1038/nrdp.2017.13
30. Zafar S YS. Parkinson Disease. StatPearls [Internet]. StatPearls Publishing; 2023. Updated August 7, 2023. Accessed August 22, 2024. https://www.ncbi.nlm.nih.gov/books/NBK470193/
31. Forni C, Facchiano F, Bartoli M, et al. Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. BioMed research international. 2019;2019:8748253. doi:10.1155/2019/8748253
32. Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential. Molecular neurodegeneration. Nov 11 2023;18(1):83. doi:10.1186/s13024-023-00676-7
33. Tan AH, Lim SY, Lang AE. The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic. Nature Reviews Neurology. 2022/08/01 2022;18(8):476-495. doi:10.1038/s41582-022-00681-2
34. AlJohri R, AlOkail M, Haq SH. Neuroprotective role of vitamin D in primary neuronal cortical culture. eNeurologicalSci. Mar 2019;14:43-48. doi:10.1016/j.ensci.2018.12.004
35. Dhana K, Evans DA, Rajan KB, Bennett DA, Morris MC. Healthy lifestyle and the risk of Alzheimer dementia. Neurology. 2020/07/28 2020;95(4):e374-e383. doi:10.1212/WNL.0000000000009816
36. Talboom JS, Håberg A, De Both MD, et al. Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors. eLife. Jun 18 2019;8doi:10.7554/eLife.46179
37. Allan CL, Ebmeier KP. The influence of ApoE4 on clinical progression of dementia: a meta-analysis. International Journal of Geriatric Psychiatry. 2011/05/01 2011;26(5):520-526. doi:https://doi.org/10.1002/gps.2559
38. Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer’s disease. BMC Medicine. 2019/03/20 2019;17(1):64. doi:10.1186/s12916-019-1299-4
39. Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nature Reviews Neurology. 2018/11/01 2018;14(11):653-666. doi:10.1038/s41582-018-0070-3
40. Yaribeygi H, Panahi Y, Javadi B, Sahebkar A. The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review. CNS & neurological disorders drug targets. 2018;17(3):207-215. doi:10.2174/1871527317666180425122557
41. Ng TK, Ho CS, Tam WW, Kua EH, Ho RC. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2019;20(2)doi:10.3390/ijms20020257
42. Tobore TO. On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease. Neurological Sciences. 2019/08/01 2019;40(8):1527-1540. doi:10.1007/s10072-019-03863-x
43. Sharma VK, Singh TG. Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease. Life sciences. 2020/12/01/ 2020;262:118401. doi:https://doi.org/10.1016/j.lfs.2020.118401
44. Kamphuis PJGH, Scheltens P. Can Nutrients Prevent or Delay Onset of Alzheimer's Disease? Journal of Alzheimer's Disease. 2010;20:765-775. doi:10.3233/JAD-2010-091558
45. Jett S, Malviya N, Schelbaum E, et al. Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention. Review. Frontiers in Aging Neuroscience. 2022;14
46. Talbot K, Wang H-Y, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. The Journal of Clinical Investigation. 04/02/ 2012;122(4):1316-1338. doi:10.1172/JCI59903
47. Bavarsad K, Hosseini M, Hadjzadeh M-A-R, Sahebkar A. The effects of thyroid hormones on memory impairment and Alzheimer's disease. Journal of Cellular Physiology. 2019/09/01 2019;234(9):14633-14640. doi:https://doi.org/10.1002/jcp.28198
48. Cortes-Canteli M, Iadecola C. Alzheimer’s Disease and Vascular Aging: JACC Focus Seminar. Journal of the American College of Cardiology. 2020/03/03/ 2020;75(8):942-951. doi:https://doi.org/10.1016/j.jacc.2019.10.062
49. Sweeney MD, Montagne A, Sagare AP, et al. Vascular dysfunction—The disregarded partner of Alzheimer's disease. Alzheimer's & Dementia. 2019/01/01 2019;15(1):158-167. doi:https://doi.org/10.1016/j.jalz.2018.07.222
50. Li Y, Li Y, Li X, et al. Head Injury as a Risk Factor for Dementia and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of 32 Observational Studies. PLOS ONE. 2017;12(1):e0169650. doi:10.1371/journal.pone.0169650
51. McKee AC, Stern RA, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain : a journal of neurology. Jan 2013;136(Pt 1):43-64. doi:10.1093/brain/aws307
52. Daulatzai MA. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease. American journal of neurodegenerative disease. 2016;5 1:1-28.
53. Yin F, Sancheti H, Patil I, Cadenas E. Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radical Biology and Medicine. 2016/11/01/ 2016;100:108-122. doi:https://doi.org/10.1016/j.freeradbiomed.2016.04.200
54. Toral-Rios D, Carvajal K, Phillips-Farfán B, Camacho-Castillo LdC, Campos-Peña V. Oxidative Stress, Metabolic Syndrome and Alzheimer’s Disease. In: Gelpi RJ, Boveris A, Poderoso JJ, eds. Biochemistry of Oxidative Stress: Physiopathology and Clinical Aspects. Springer International Publishing; 2016:361-374.
55. Wu Z, Yu J, Zhu A, Nakanishi H. Nutrients, Microglia Aging, and Brain Aging. Oxidative Medicine and Cellular Longevity. 2016/01/01 2016;2016(1):7498528. doi:https://doi.org/10.1155/2016/7498528
56. Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nature reviews Neuroscience. Jul 2008;9(7):568-78. doi:10.1038/nrn2421
57. Fransquet PD, Lacaze P, Saffery R, McNeil J, Woods R, Ryan J. Blood DNA methylation as a potential biomarker of dementia: A systematic review. Alzheimer's & Dementia. 2018/01/01 2018;14(1):81-103. doi:https://doi.org/10.1016/j.jalz.2017.10.002
58. Wang Q, Zhao J, Chang H, Liu X, Zhu R. Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis. Systematic Review. Frontiers in Aging Neuroscience. 2021;13
59. Jernerén F, Cederholm T, Refsum H, et al. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study. Journal of Alzheimer's Disease. 2019;69:189-197. doi:10.3233/JAD-181148
60. Bianchi VE. Impact of Testosterone on Alzheimer’s Disease. World J Mens Health. 4/ 2022;40(2):243-256.
61. Henderson VW. Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention after menopause. The Journal of Steroid Biochemistry and Molecular Biology. 2014/07/01/ 2014;142:99-106. doi:https://doi.org/10.1016/j.jsbmb.2013.05.010
62. Arnold SE, Arvanitakis Z, Macauley-Rambach SL, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews Neurology. 2018/03/01 2018;14(3):168-181. doi:10.1038/nrneurol.2017.185
63. Csernansky JG, Dong H, Fagan AM, et al. Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia. American Journal of Psychiatry. 2006/12/01 2006;163(12):2164-2169. doi:10.1176/ajp.2006.163.12.2164
64. Tan ZS, Vasan RS. Thyroid Function and Alzheimer's Disease. Journal of Alzheimer's Disease. 2009;16:503-507. doi:10.3233/JAD-2009-0991
65. Bakulski KM, Seo YA, Hickman RC, et al. Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias. Journal of Alzheimer's Disease. 2020;76:1215-1242. doi:10.3233/JAD-200282
66. Yan D, Zhang Y, Liu L, Yan H. Pesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis. Scientific Reports. 2016/09/01 2016;6(1):32222. doi:10.1038/srep32222
67. Krepel SA, O'Hara L, Mangum S, Hogan MB, Kuhn TB. Inflammatory stress induces a biphasic Nrf2 activation in neuronal cells. The FASEB Journal. 2017/04/01 2017;31(S1):779.3-779.3. doi:https://doi.org/10.1096/fasebj.31.1_supplement.779.3
68. Pei X, Zhang W, Jiang H, et al. Food-Origin Mycotoxin-Induced Neurotoxicity: Intend to Break the Rules of Neuroglia Cells. Oxidative Medicine and Cellular Longevity. 2021/01/01 2021;2021(1):9967334. doi:https://doi.org/10.1155/2021/9967334
69. Guilford FT, Hope J. Deficient Glutathione in the Pathophysiology of Mycotoxin-Related Illness. Toxins. 2014;6(2):608-623. doi:10.3390/toxins6020608
70. Granerod J, Ambrose HE, Davies NWS, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. The Lancet Infectious Diseases. 2010;10(12):835-844. doi:10.1016/S1473-3099(10)70222-X
71. Barnes LL, Capuano AW, Aiello AE, et al. Cytomegalovirus Infection and Risk of Alzheimer Disease in Older Black and White Individuals. The Journal of Infectious Diseases. 2014;211(2):230-237. doi:10.1093/infdis/jiu437
72. Ou Y-N, Zhu J-X, Hou X-H, et al. Associations of Infectious Agents with Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease. 2020;75:299-309. doi:10.3233/JAD-191337
73. Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts. The FASEB Journal. 2017/08/01 2017;31(8):3216-3226. doi:https://doi.org/10.1096/fj.201700360
74. Huang S-Y, Yang Y-X, Kuo K, et al. Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study. Alzheimer's Research & Therapy. 2021/09/24 2021;13(1):158. doi:10.1186/s13195-021-00905-5
75. Iadecola C. The Pathobiology of Vascular Dementia. Neuron. 2013;80(4):844-866. doi:10.1016/j.neuron.2013.10.008
76. van den Beukel TC, Wolters FJ, Siebert U, et al. Intracranial arteriosclerosis and the risk of dementia: A population-based cohort study. Alzheimer's & Dementia. 2024/02/01 2024;20(2):869-879. doi:https://doi.org/10.1002/alz.13496
77. Sierra C. Hypertension and the Risk of Dementia. Mini Review. Frontiers in Cardiovascular Medicine. 2020;7
78. Baugh CM, Stamm JM, Riley DO, et al. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging and Behavior. 2012/06/01 2012;6(2):244-254. doi:10.1007/s11682-012-9164-5
79. Bruggeman GF, Haitsma IK, Dirven CMF, Volovici V. Traumatic axonal injury (TAI): definitions, pathophysiology and imaging-a narrative review. Acta neurochirurgica. Jan 2021;163(1):31-44. doi:10.1007/s00701-020-04594-1
80. Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. Journal of neurotrauma. Aug 2010;27(8):1529-40. doi:10.1089/neu.2010.1358
81. Broshek DK, Kaushik T, Freeman JR, Erlanger D, Webbe F, Barth JT. Sex differences in outcome following sports-related concussion. Journal of Neurosurgery. 01 Jan. 2005 2005;102(5):856-863. doi:https://doi.org/10.3171/jns.2005.102.5.0856
82. Davis GA, Purcell LK. The evaluation and management of acute concussion differs in young children. British Journal of Sports Medicine. 2014;48(2):98-101. doi:10.1136/bjsports-2012-092132
83. Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging. Mayo Clinic Proceedings. 2011;86(9):876-884. doi:10.4065/mcp.2011.0252
84. Shi L, Chen S-J, Ma M-Y, et al. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Medicine Reviews. 2018/08/01/ 2018;40:4-16. doi:https://doi.org/10.1016/j.smrv.2017.06.010
85. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. The Lancet Neurology. 2004;3(6):343-353. doi:10.1016/S1474-4422(04)00767-7
86. Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK. Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications. Molecular neurodegeneration. Mar 16 2023;18(1):18. doi:10.1186/s13024-023-00605-8
87. Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. Jama. Aug 25 2020;324(8):772-781. doi:10.1001/jama.2020.12134
88. Palmqvist S, Tideman P, Mattsson-Carlgren N, et al. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. Jama. 2024;doi:10.1001/jama.2024.13855 %J JAMA
89. Narayanan S, Shanker A, Khera T, Subramaniam B. Neurofilament light: a narrative review on biomarker utility. Faculty reviews. 2021;10:46. doi:10.12703/r/10-46
90. Khalil M, Teunissen CE, Otto M, et al. Neurofilaments as biomarkers in neurological disorders. Nature Reviews Neurology. 2018/10/01 2018;14(10):577-589. doi:10.1038/s41582-018-0058-z
91. Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature reviews Neurology. Feb 2013;9(2):106-18. doi:10.1038/nrneurol.2012.263
92. Pankratova N, Jović M, Pfeifer ME. Electrochemical sensing of blood proteins for mild traumatic brain injury (mTBI) diagnostics and prognostics: towards a point-of-care application. RSC advances. May 12 2021;11(28):17301-17319. doi:10.1039/d1ra00589h
93. Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends in neurosciences. Jun 2015;38(6):364-74. doi:10.1016/j.tins.2015.04.003
94. Arce Rentería M, Gillett SR, McClure LA, et al. C-reactive protein and risk of cognitive decline: The REGARDS study. PLoS One. 2020;15(12):e0244612. doi:10.1371/journal.pone.0244612
95. Smith AD, Refsum H. Homocysteine, B Vitamins, and Cognitive Impairment. Annual Review of Nutrition. 2016;36(Volume 36, 2016):211-239. doi:https://doi.org/10.1146/annurev-nutr-071715-050947
96. Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochimica et biophysica acta Molecular basis of disease. May 2017;1863(5):1037-1045. doi:10.1016/j.bbadis.2016.04.017
97. Rebouças BH, Kubota GT, Oliveira RAA, et al. Long-Term Environmental Methylmercury Exposure Is Associated with Peripheral Neuropathy and Cognitive Impairment among an Amazon Indigenous Population. Toxics. Mar 12 2024;12(3)doi:10.3390/toxics12030212
98. AK AK BB, Mendez MD,. Herpes Simplex Encephalitis. StatPearls [Internet]. StatPearls Publishing; 2024. Updated January 19, 2024. Accessed August 22, 2024. https://www.ncbi.nlm.nih.gov/books/NBK557643/
99. Garcia HH, Gonzalez AE, Gilman RH. Taenia solium Cysticercosis and Its Impact in Neurological Disease. Clinical microbiology reviews. Jun 17 2020;33(3)doi:10.1128/cmr.00085-19
100. Mohanty S, Johansson Kostenniemi U, Silfverdal SA, et al. Increased Risk of Long-Term Disabilities Following Childhood Bacterial Meningitis in Sweden. JAMA network open. Jan 2 2024;7(1):e2352402. doi:10.1001/jamanetworkopen.2023.52402
101. Ehsanifar M, Rajati R, Gholami A, Reiss JP. Mold and Mycotoxin Exposure and Brain Disorders. J Integr Neurosci. 2023-11-21 2023;22(6)doi:10.31083/j.jin2206137
102. Cooper J, Pastorello Y, Slevin M. A meta-analysis investigating the relationship between inflammation in autoimmune disease, elevated CRP, and the risk of dementia. Frontiers in immunology. 2023;14:1087571. doi:10.3389/fimmu.2023.1087571
103. Ehtewish H, Mesleh A, Ponirakis G, et al. Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia. Frontiers in neurology. 2023;14:1256745. doi:10.3389/fneur.2023.1256745
104. Jack CR, Jr., Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association. Apr 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018
105. Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. Sep 2 2014;83(10):920-8. doi:10.1212/wnl.0000000000000755
106. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. The Journal of endocrinology. Oct 2005;187(1):1-15. doi:10.1677/joe.1.06131
107. Cohen S, Janicki-Deverts D, Miller GE. Psychological Stress and Disease. Jama. 2007;298(14):1685-1687. doi:10.1001/jama.298.14.1685 %J JAMA
108. Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimer's & dementia : the journal of the Alzheimer's Association. Sep 2015;11(9):1015-22. doi:10.1016/j.jalz.2015.04.011
109. The Nutrition Source. Diet Review: MIND Diet. Harvard T H Chan School of Public Health blog. 2023. Accessed August 22, 2024. https://nutritionsource.hsph.harvard.edu/healthy-weight/diet-reviews/mind-diet/
110. Pérez-Guisado J, Muñoz-Serrano A, Alonso-Moraga Á. Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss. Nutrition Journal. 2008/10/26 2008;7(1):30. doi:10.1186/1475-2891-7-30
111. Nanda M, Pradhan G, Singh V, Barve K. Ketogenic diets: Answer to life-threatening neurological diseases. Food and Humanity. 2024/12/01/ 2024;3:100364. doi:https://doi.org/10.1016/j.foohum.2024.100364
112. Neth BJ, Mintz A, Whitlow C, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study. Neurobiology of Aging. 2020/02/01/ 2020;86:54-63. doi:https://doi.org/10.1016/j.neurobiolaging.2019.09.015
113. Schweickart A, Batra R, Neth BJ, et al. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis. medRxiv Preprint. Nov 27 2023;doi:10.1101/2023.11.27.23298990
114. Sheffler JL, Kiosses DN, He Z, et al. Improving Adherence to a Mediterranean Ketogenic Nutrition Program for High-Risk Older Adults: A Pilot Randomized Trial. Nutrients. May 16 2023;15(10)doi:10.3390/nu15102329
115. Kawas MI, Lockhart SN, Kim J, et al. Modified Mediterranean ketogenic diet resolves default mode network connectivity differences between adults with normal and impaired cognition. Alzheimer's & Dementia. 2021/12/01 2021;17(S1):e056711. doi:https://doi.org/10.1002/alz.056711
116. Toups K, Hathaway A, Gordon D, et al. Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project. Journal of Alzheimer's disease : JAD. 2022;88(4):1411-1421. doi:10.3233/jad-215707
117. Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia. 2015/09/01 2015;11(9):1007-1014. doi:https://doi.org/10.1016/j.jalz.2014.11.009
118. Wierenga KA, Pestka JJ. Omega-3 Fatty Acids And Inflammation - You Are What You Eat! Frontiers for young minds. 2021;9doi:10.3389/frym.2021.601068
119. Khan J, Gul P, Rashid MT, Li Q, Liu K. Composition of Whole Grain Dietary Fiber and Phenolics and Their Impact on Markers of Inflammation. Nutrients. Apr 3 2024;16(7)doi:10.3390/nu16071047
120. National Institutes of Health-Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. Updated February 15, 2023. Accessed August 16, 2022, https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
121. Romani A, Ieri F, Urciuoli S, et al. Health Effects of Phenolic Compounds Found in Extra-Virgin Olive Oil, By-Products, and Leaf of Olea europaea L. Nutrients. Aug 1 2019;11(8)doi:10.3390/nu11081776
122. Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. New England Journal of Medicine. 2018/06/21 2018;378(25):e34. doi:10.1056/NEJMoa1800389
123. Hamaguchi T, Ono K, Yamada M. REVIEW: Curcumin and Alzheimer's disease. CNS neuroscience & therapeutics. Oct 2010;16(5):285-97. doi:10.1111/j.1755-5949.2010.00147.x
124. Krikorian R, Shidler MD, Nash TA, et al. Blueberry supplementation improves memory in older adults. Journal of agricultural and food chemistry. Apr 14 2010;58(7):3996-4000. doi:10.1021/jf9029332
125. Skrovankova S, Sumczynski D, Mlcek J, Jurikova T, Sochor J. Bioactive Compounds and Antioxidant Activity in Different Types of Berries. Int J Mol Sci. Oct 16 2015;16(10):24673-706. doi:10.3390/ijms161024673
126. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chinese medicine. Apr 6 2010;5:13. doi:10.1186/1749-8546-5-13
127. Scholey A, Owen L. Effects of chocolate on cognitive function and mood: a systematic review. Nutrition Reviews. 2013;71(10):665-681. doi:10.1111/nure.12065 %J Nutrition Reviews
128. Samanta S, Sarkar T, Chakraborty R, et al. Dark chocolate: An overview of its biological activity, processing, and fortification approaches. Current research in food science. 2022;5:1916-1943. doi:10.1016/j.crfs.2022.10.017
129. National Institutes on Aging. Beyond the brain: The gut microbiome and Alzheimer’s disease. Updated June 12, 2023. Accessed August 22, 2024, https://www.nia.nih.gov/news/beyond-brain-gut-microbiome-and-alzheimers-disease
130. Tanaka K, Farooqui AA, Siddiqi NJ, Alhomida AS, Ong WY. Effects of docosahexaenoic Acid on neurotransmission. Biomolecules & therapeutics. Mar 2012;20(2):152-7. doi:10.4062/biomolther.2012.20.2.152
131. Borsini A, Nicolaou A, Camacho-Muñoz D, et al. Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis. Molecular psychiatry. Nov 2021;26(11):6773-6788. doi:10.1038/s41380-021-01160-8
132. Dighriri IM, Alsubaie AM, Hakami FM, et al. Effects of Omega-3 Polyunsaturated Fatty Acids on Brain Functions: A Systematic Review. Cureus. Oct 2022;14(10):e30091. doi:10.7759/cureus.30091
133. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American journal of clinical nutrition. Jun 2006;83(6 Suppl):1505s-1519s. doi:10.1093/ajcn/83.6.1505S
134. Ford TC, Downey LA, Simpson T, McPhee G, Oliver C, Stough C. The Effect of a High-Dose Vitamin B Multivitamin Supplement on the Relationship between Brain Metabolism and Blood Biomarkers of Oxidative Stress: A Randomized Control Trial. Nutrients. Dec 1 2018;10(12)doi:10.3390/nu10121860
135. Paul C, Brady DM. Comparative Bioavailability and Utilization of Particular Forms of B(12) Supplements With Potential to Mitigate B(12)-related Genetic Polymorphisms. Integrative medicine (Encinitas, Calif). Feb 2017;16(1):42-49.
136. Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. Nutrients. Jan 27 2016;8(2):68. doi:10.3390/nu8020068
137. Morris MS. The role of B vitamins in preventing and treating cognitive impairment and decline. Advances in nutrition (Bethesda, Md). Nov 1 2012;3(6):801-12. doi:10.3945/an.112.002535
138. Kumar A, Verma A, Chaurasia RN. Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects. Neuroscience Letters. 2023/01/31/ 2023;795:137044. doi:https://doi.org/10.1016/j.neulet.2022.137044
139. Gáll Z, Székely O. Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings. Nutrients. Oct 20 2021;13(11)doi:10.3390/nu13113672
140. Chai B, Gao F, Wu R, et al. Vitamin D deficiency as a risk factor for dementia and Alzheimer's disease: an updated meta-analysis. BMC neurology. Nov 13 2019;19(1):284. doi:10.1186/s12883-019-1500-6
141. Maier JAM, Locatelli L, Fedele G, Cazzaniga A, Mazur A. Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration. Int J Mol Sci. Dec 23 2022;24(1)doi:10.3390/ijms24010223
142. Barbagallo M, Dominguez LJ. Magnesium and aging. Current pharmaceutical design. 2010;16(7):832-9. doi:10.2174/138161210790883679
143. Garodia P, Hegde M, Kunnumakkara AB, Aggarwal BB. Curcumin, inflammation, and neurological disorders: How are they linked? Integrative medicine research. Sep 2023;12(3):100968. doi:10.1016/j.imr.2023.100968
144. Askarizadeh A, Barreto GE, Henney NC, Majeed M, Sahebkar A. Neuroprotection by curcumin: A review on brain delivery strategies. International Journal of Pharmaceutics. 2020/07/30/ 2020;585:119476. doi:https://doi.org/10.1016/j.ijpharm.2020.119476
145. Small GW, Siddarth P, Li Z, et al. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. The American Journal of Geriatric Psychiatry. 2018;26(3):266-277. doi:10.1016/j.jagp.2017.10.010
146. Kim HY, Huang BX, Spector AA. Phosphatidylserine in the brain: metabolism and function. Progress in lipid research. Oct 2014;56:1-18. doi:10.1016/j.plipres.2014.06.002
147. Ma X, Li X, Wang W, Zhang M, Yang B, Miao Z. Phosphatidylserine, inflammation, and central nervous system diseases. Front Aging Neurosci. 2022;14:975176. doi:10.3389/fnagi.2022.975176
148. Glade MJ, Smith K. Phosphatidylserine and the human brain. Nutrition (Burbank, Los Angeles County, Calif). Jun 2015;31(6):781-6. doi:10.1016/j.nut.2014.10.014
149. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. Jul 2019;16(3):666-674. doi:10.1007/s13311-019-00767-8
150. Tan M-S, Yu J-T, Tan C-C, et al. Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease. 2015;43:589-603. doi:10.3233/JAD-140837
151. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC geriatrics. Mar 17 2010;10:14. doi:10.1186/1471-2318-10-14
152. Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular biotechnology. Sep 2007;37(1):31-7. doi:10.1007/s12033-007-0052-y
153. Beal MF. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. Journal of bioenergetics and biomembranes. Aug 2004;36(4):381-6. doi:10.1023/b:Jobb.0000041772.74810.92
154. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid. Free Radical Biology and Medicine. 1997/01/01/ 1997;22(1):359-378. doi:https://doi.org/10.1016/S0891-5849(96)00269-9
155. Moini H, Packer L, Saris N-EL. Antioxidant and Prooxidant Activities of α-Lipoic Acid and Dihydrolipoic Acid. Toxicology and Applied Pharmacology. 2002/07/01/ 2002;182(1):84-90. doi:https://doi.org/10.1006/taap.2002.9437
156. Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiology of Aging. 1995/01/01/ 1995;16(1):1-4. doi:https://doi.org/10.1016/0197-4580(95)80001-8
157. Wunderlin M, Züst MA, Fehér KD, Klöppel S, Nissen C. The role of slow wave sleep in the development of dementia and its potential for preventative interventions. Psychiatry Research: Neuroimaging. 2020/12/30/ 2020;306:111178. doi:https://doi.org/10.1016/j.pscychresns.2020.111178
158. Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science (New York, NY). Oct 2 2020;370(6512):50-56. doi:10.1126/science.abb8739
159. Winer JR, Mander BA, Kumar S, et al. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. Current biology : CB. Nov 2 2020;30(21):4291-4298.e3. doi:10.1016/j.cub.2020.08.017
160. Andrade AG, Bubu OM, Varga AW, Osorio RS. The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2018;64(s1):S255-s270. doi:10.3233/jad-179936
161. Kumar A SJ, Lui F, Tsao JW,. Alzheimer Disease. StatPearls [Internet]. StatPearls Publishing; 2024. Updated February 12, 2024. Accessed August 22, 2024. https://www.ncbi.nlm.nih.gov/books/NBK499922/
162. Wal P, Vig H, Wal A, et al. Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management. Current aging science. 2023;16(3):170-187. doi:10.2174/1874609816666230515121717
163. Wang K, Li K, Zhang P, et al. Mind–Body Exercises for Non-motor Symptoms of Patients With Parkinson’s Disease: A Systematic Review and Meta-Analysis. Systematic Review. Frontiers in Aging Neuroscience. 2021;13
164. Erickson KI, Hillman CH, Kramer AF. Physical activity, brain, and cognition. Current Opinion in Behavioral Sciences. 2015/08/01/ 2015;4:27-32. doi:https://doi.org/10.1016/j.cobeha.2015.01.005
165. Lin X, Zhang X, Guo J, et al. Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2015;4(7):e002014. doi:10.1161/JAHA.115.002014
166. Ho G, Takamatsu Y, Waragai M, et al. Current and future clinical utilities of Parkinson’s disease and dementia biomarkers: can they help us conquer the disease? Expert Review of Neurotherapeutics. 2019/11/02 2019;19(11):1149-1161. doi:10.1080/14737175.2019.1649141
167. Cleveland Clinic. The (Many) Benefits of a Cardio Workout. Cleveland Clinic Health; May 9, 2023. Accessed August 22, 2024, https://health.clevelandclinic.org/the-many-benefits-of-a-cardio-workout
168. Cleveland Clinic. How Exercise Protects Your Brain’s Health. Cleveland Clinic Health; September 27, 2022. Accessed August 22, 2024, https://health.clevelandclinic.org/exercise-and-brain-health
169. Qiu X, Xiao Y, Wu J, Gan L, Huang Y, Wang J. C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis. Systematic Review. Frontiers in neurology. 2019;10
170. Kasapis C, Thompson PD. The Effects of Physical Activity on Serum C-Reactive Protein and Inflammatory Markers: A Systematic Review. Journal of the American College of Cardiology. 2005/05/17/ 2005;45(10):1563-1569. doi:https://doi.org/10.1016/j.jacc.2004.12.077
171. Rojas-Valverde D, Bonilla DA, Gómez-Miranda LM, Calleja-Núñez JJ, Arias N, Martínez-Guardado I. Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. Biomedicines. 2023;11(8). doi:10.3390/biomedicines11082267
172. Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X. The Impact of Mind-Body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson’s Disease: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2020;17(1). doi:10.3390/ijerph17010031
173. Fereydouni Balangani S. Neuroscience, Neurotransmitters and Interpersonal Relationships. International Journal of BioLife Sciences (IJBLS). 2024;3(2):108-108. doi:10.22034/ijbls.2024.196279
174. Lydon EA, Nguyen LT, Nie Q, Rogers WA, Mudar RA. An Integrative Framework to Guide Social Engagement Interventions and Technology Design for Persons With Mild Cognitive Impairment. Frontiers in public health. 2021;9:750340. doi:10.3389/fpubh.2021.750340
175. Samtani S, Mahalingam G, Lam BCP, et al. Associations between social connections and cognition: a global collaborative individual participant data meta-analysis. The lancet Healthy longevity. Nov 2022;3(11):e740-e753. doi:10.1016/s2666-7568(22)00199-4
176. Rayland A, Andrews J. From Social Network to Peer Support Network: Opportunities to Explore Mechanisms of Online Peer Support for Mental Health. JMIR mental health. Feb 28 2023;10:e41855. doi:10.2196/41855
177. Llanque S, Savage L, Rosenburg N, Caserta M. Concept Analysis: Alzheimer's Caregiver Stress. Nursing Forum. 2016/01/01 2016;51(1):21-31. doi:https://doi.org/10.1111/nuf.12090
178. Drentea P, Clay OJ, Roth DL, Mittelman MS. Predictors of improvement in social support: Five-year effects of a structured intervention for caregivers of spouses with Alzheimer's disease. Social Science & Medicine. 2006/08/01/ 2006;63(4):957-967. doi:https://doi.org/10.1016/j.socscimed.2006.02.020
179. Rao RV, Kumar S, Gregory J, et al. ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. Biomedicines. Sep 29 2021;9(10)doi:10.3390/biomedicines9101348
180. Luan YY, Yao YM. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases. Frontiers in immunology. 2018;9:1302. doi:10.3389/fimmu.2018.01302
181. Rocamonde B, Hasan U, Mathieu C, Dutartre H. Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses. Frontiers in neuroscience. 2023;17:1108212. doi:10.3389/fnins.2023.1108212
182. Janicki SC, Schupf N. Hormonal influences on cognition and risk for Alzheimer's disease. Current neurology and neuroscience reports. Sep 2010;10(5):359-66. doi:10.1007/s11910-010-0122-6
183. Herman JP, McKlveen JM, Ghosal S, et al. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. Comprehensive Physiology. Mar 15 2016;6(2):603-21. doi:10.1002/cphy.c150015
184. Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, et al. Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. Feb 13 2023;24(4)doi:10.3390/ijms24043754
185. Wu SM, Chen ZF, Young L, Shiao SP. Meta-Prediction of the Effect of Methylenetetrahydrofolate Reductase Polymorphisms and Air Pollution on Alzheimer's Disease Risk. Int J Environ Res Public Health. Jan 11 2017;14(1)doi:10.3390/ijerph14010063
186. Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Frontiers in cellular neuroscience. 2015;9:124. doi:10.3389/fncel.2015.00124
187. Hope J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. TheScientificWorldJournal. 2013;2013:767482. doi:10.1155/2013/767482
188. Elonheimo HM, Andersen HR, Katsonouri A, Tolonen H. Environmental Substances Associated with Alzheimer's Disease-A Scoping Review. Int J Environ Res Public Health. Nov 11 2021;18(22)doi:10.3390/ijerph182211839
189. Chen Y, Xu J, Chen Y. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients. Jun 19 2021;13(6)doi:10.3390/nu13062099
190. Chang CH, Lin CH, Lane HY. d-glutamate and Gut Microbiota in Alzheimer's Disease. Int J Mol Sci. Apr 11 2020;21(8)doi:10.3390/ijms21082676
191. Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Annals of the New York Academy of Sciences. Jul 2012;1258(1):25-33. doi:10.1111/j.1749-6632.2012.06538.x
192. Kang JM, Cho YS, Park S, et al. Montreal cognitive assessment reflects cognitive reserve. BMC geriatrics. Oct 30 2018;18(1):261. doi:10.1186/s12877-018-0951-8
193. Villa C, Lavitrano M, Salvatore E, Combi R. Molecular and Imaging Biomarkers in Alzheimer's Disease: A Focus on Recent Insights. Journal of personalized medicine. Jul 10 2020;10(3)doi:10.3390/jpm10030061
194. Song T, Song X, Zhu C, et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing research reviews. Dec 2021;72:101503. doi:10.1016/j.arr.2021.101503
195. Peng Y, Gao P, Shi L, Chen L, Liu J, Long J. Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention. Antioxidants & redox signaling. Jun 1 2020;32(16):1188-1236. doi:10.1089/ars.2019.7763
196. Fei HX, Qian CF, Wu XM, Wei YH, Huang JY, Wei LH. Role of micronutrients in Alzheimer's disease: Review of available evidence. World journal of clinical cases. Aug 6 2022;10(22):7631-7641. doi:10.12998/wjcc.v10.i22.7631
197. Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L. Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Biochimica et biophysica acta. Jun 2015;1852(6):1202-8. doi:10.1016/j.bbadis.2014.10.006
198. Zhou C, Wu Q, Wang Z, Wang Q, Liang Y, Liu S. The Effect of Hormone Replacement Therapy on Cognitive Function in Female Patients With Alzheimer's Disease: A Meta-Analysis. American journal of Alzheimer's disease and other dementias. Jan-Dec 2020;35:1533317520938585. doi:10.1177/1533317520938585
199. Khalsa DS. Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands. Journal of Alzheimer's disease : JAD. 2015;48(1):1-12. doi:10.3233/jad-142766
200. Rao RV, Subramaniam KG, Gregory J, et al. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review. Int J Mol Sci. Jan 14 2023;24(2)doi:10.3390/ijms24021659
201. Zhang S, Zhen K, Su Q, Chen Y, Lv Y, Yu L. The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Environ Res Public Health. Nov 25 2022;19(23)doi:10.3390/ijerph192315700
202. Casagrande M, Forte G, Favieri F, Corbo I. Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer's Disease. Int J Environ Res Public Health. Jul 11 2022;19(14)doi:10.3390/ijerph19148457
203. Ballesteros S, Prieto A, Mayas J, et al. Corrigendum: Brain training with non-action video games enhances aspects of cognition in older adults: a randomized controlled trial. Front Aging Neurosci. 2015;7:82. doi:10.3389/fnagi.2015.00082
FUNCTION HEALTH IS A HEALTHCARE TECHNOLOGY COMPANY AND NOT A LABORATORY OR MEDICAL PROVIDER. ALL LABORATORY AND MEDICAL SERVICES ARE PROVIDED BY INDEPENDENT THIRD PARTIES. FUNCTION HEALTH DOES NOT OFFER MEDICAL ADVICE, LABORATORY SERVICES, A DIAGNOSIS, MEDICAL TREATMENT, OR ANY FORM OF MEDICAL OPINION, THROUGH OUR SERVICES OR OTHERWISE. FUNCTION HEALTH’S SERVICES ARE NOT A SUBSTITUTE FOR MEDICAL CARE, MEDICAL ADVICE, AND/OR A DETAILED DISCUSSION WITH YOUR PRIMARY CARE PHYSICIAN OR OTHER LICENSED PROVIDER. IF YOU HAVE ANY QUESTIONS REGARDING ANY LABORATORY RESULTS OR OTHER INFORMATION THAT YOU ACCESS THROUGH FUNCTION HEALTH, WE RECOMMEND THAT YOU DISCUSS THOSE QUESTIONS WITH A PRIMARY CARE PHYSICIAN OR OTHER LICENSED PROVIDER. ALL MATERIAL, INFORMATION, DATA, AND CONTENT THAT FUNCTION HEALTH PROVIDES IS STRICTLY FOR GENERAL INFORMATION PURPOSES.
WITHOUT LIMITATION, THE IDEAS AND INFORMATION PROVIDED IN THIS BRAIN HEALTH 101 GUIDE ARE STRICTLY FOR GENERAL INFORMATION PURPOSES AND DO NOT CONSTITUTE ANY FORM OF MEDICAL ADVICE OR A MEDICAL OPINION. EACH INDIVIDUAL, INCLUDING YOURSELF, PRESENTS A UNIQUE SET OF HEALTH REQUIREMENTS, RESTRICTIONS, LIMITS, AND OTHER NEEDS – IN ADDITION TO POTENTIAL ALLERGIES, AS WELL AS POSSIBLE CONTRAINDICATIONS WITH CURRENT MEDICATIONS – AND THIS BRAIN HEALTH 101 GUIDE DOES NOT ACCOUNT FOR THOSE INDIVIDUAL CIRCUMSTANCES. MOREOVER, SCIENTIFIC RESEARCH AND KNOWLEDGE ON THE TOPIC OF WEIGHT UNDERGO CONTINUOUS REASSESSMENT AND EVALUATION; FUNCTION MAKES NO WARRANTY REGARDING THE ACCURACY, RELIABILITY, EFFICACY, TIMELINESS, OR VALUE OF THE INFORMATION CONTAINED IN THIS BRAIN HEALTH 101 GUIDE. PLEASE CONSULT WITH YOUR PRIMARY CARE PHYSICIAN OR ANOTHER LICENSED MEDICAL PROVIDER BEFORE MAKING ANY CHANGES RELATING TO YOUR DIET, EXERCISE, SLEEP SCHEDULE, LIFESTYLE, MEDICATION REGIMEN, SUPPLEMENT INTAKE, AND/OR OTHER DAILY PRACTICES.
Unlock 100 healthy years.